Stay updated on Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 is added to the record history, updating the study's version history. The previous revision v3.5.3 is removed from the list.
    Difference
    0.1%
    Check dated 2026-05-15T05:41:46.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page’s footer updates the ClinicalTrials.gov build/release revision from **v3.5.2** to **v3.5.3**, indicating a web/version update. No study-specific content or record-history details are altered.
    Difference
    0.1%
    Check dated 2026-04-24T05:46:44.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 to the history. Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:13:03.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and revision v3.4.3 was removed from the Record History.
    Difference
    0.1%
    Check dated 2026-03-19T04:25:27.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Record History now shows Revision: v3.4.3 and removes Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T18:48:48.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Minor changes include the addition of Revision: v3.4.2 and the removal of a funding notice, which do not affect the study data, status, or history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-11T09:22:36.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial page.